Remote Jobs at NewAmsterdam Pharma Corporation

NewAmsterdam Pharma Corporation

51 - 200 employees

Founded 2019

🏥 Healthcare

🧬 Biotechnology

💊 Pharmaceuticals

💰 $175.3M Post IPO equity on 2024-03

Healthcare • Biotechnology • Pharmaceuticals

NewAmsterdam Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing therapies for cardiovascular disease and other lipid-related conditions. The company is advancing obicetrapib, a CETP inhibitor, and other programs aimed at lowering LDL-C and reducing cardiovascular risk for patients who have unmet needs despite existing lipid-lowering treatments. NewAmsterdam emphasizes science-backed development, clinical trials, and patient-focused initiatives.